Vanberra Signal
Enygma logo

Enygma

Curated by Signal

Payment fraud detection platform offering real-time risk scoring solutions.

Overview

Enygma is a company that specializes in payment fraud detection. It offers a suite of software aimed at preventing financial crime, which is designed to enhance transaction security for banking institutions, Payment Service Providers, and iGaming companies. The company utilizes advanced algorithms and machine learning to provide real-time risk scoring and transaction monitoring, which assists businesses in identifying and mitigating fraudulent activities. Enygma's solutions are designed to integrate with third-party systems and comply with data privacy regulations while maintaining user privacy. The company's focus is on helping businesses reduce the risks associated with financial fraud, which may contribute to fostering trust in digital financial services. The platform includes capabilities for rapid transaction analysis and supports strong customer authentication exemptions, addressing specific challenges within the fintech sector.

Key facts

Founded
2011

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Fraud & Identity companies
  • Fraud detection platform ensuring compliance and security in transactions.

    Fraud & IdentitySan Francisco, United States
  • Payment fraud detection platform enhancing security and customer experience.

    Fraud & IdentitySofia, Bulgaria
  • Payment fraud detection platform enhancing security for financial transactions.

    Fraud & IdentityTel Aviv, Israel
+ 218 more similar companies on Signal

About Enygma

What does Enygma do?

Enygma is a company that specializes in payment fraud detection.

Where is Enygma headquartered?

Enygma is headquartered in Allen, United States.

When was Enygma founded?

Enygma was founded in 2011.

Which sector is Enygma in?

Enygma operates in Fraud & Identity, part of Financial Technology.

Who are Enygma's competitors?

Companies similar to Enygma include Gueno, Notolytix, and Alterya.